BOK Financial Corporation enters the week after its Q1 print with short sellers in retreat — yet the options market is growing more cautious than it has been all year.
Short interest has fallen sharply from its recent peak. The SI % of free float hit 14.1% on April 22 — the highest level recorded in the trailing 30-day window — before dropping back to 12.5% by April 28. That's a meaningful eight-session unwind of roughly 1.6 percentage points. The week-on-week decline in shares short was 8.3%, one of the steeper one-week reductions in recent months. The lending market tells the same story: the cost to borrow is just 0.45% annualised, down 17% on the week, and availability remains ample, suggesting no squeeze mechanics are in play. Borrow availability is well off its tightest levels of the past year.
The options picture diverges from that ease. The put/call ratio has climbed to 0.36 — about 1.6 standard deviations above its 20-day average of 0.29 — making this the most defensive options positioning of the past several weeks. That's still far below the 52-week high of 1.46, so this is not panic hedging. But the directional shift is notable: options traders have been adding puts even as shorts have been covering, pointing to residual caution around the next catalyst.
The Street's reaction to Q1 was measured but constructive. Citigroup and DA Davidson both lifted their price targets this week — to $138 and $139 respectively — while maintaining Neutral ratings. RBC Capital raised its target further to $145, holding Sector Perform. Barclays had already moved to $145 in early April. The direction of travel is unambiguous: every firm that touched the name in recent weeks raised their number. But none upgraded. The consensus view is that BOKF is fairly valued at current levels, with a mean target of $144 against a close of $133.97 — modest upside of around 7%. Factor scores lean the same way: EPS momentum over 30 days ranks in the 85th percentile, and EPS surprise sits at 75th, suggesting the Q1 beat was real. The 12-month forward EPS growth picture is weaker, ranking just 23rd percentile, which likely explains why the upgrades aren't coming.
Ownership is shaped by one dominant fact: Chairman George Kaiser controls around 62.5% of shares, making the float unusually tight and concentrated. Among institutional holders, FMR (Fidelity) added 350,000 shares as of end-February, and BlackRock added roughly 100,000 shares through March. State Street also added 127,000 shares in the same period. These are not activist moves, but the directional drift from index and active managers is modestly positive. Insider activity is modest in scale. The HR Director sold around $163,000 in shares on April 23, a routine transaction carrying low significance scores. Net insider activity over the past 90 days is slightly positive in share terms but driven by equity awards rather than open-market buying — not a strong directional signal.
The Q1 earnings print was the most recent reference point for how the stock absorbs results. The stock slipped 1.5% the day after the April 21 announcement and was down 2.3% over the following five sessions. That's a mild negative reaction — not a collapse — and the stock has broadly stabilised around $134. The next scheduled event is May 5, which appears to be a follow-on earnings call or conference. Peers had a notably different week: UMBF and SFNC both rose roughly 1.9% over the same period, while LOB surged 6.5%. BOKF's near-flat week contrasts with the broader regional bank recovery, which may partly explain why options traders are adding puts even as shorts retreat.
The key tension to watch is whether the short interest re-accumulation that ran from early April into the April 22 peak was the full move, or merely the first leg — with the next catalyst being whatever the May 5 event surfaces.
See the live data behind this article on ORTEX.
Open BOKF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.